Edition:
United Kingdom

Cymabay Therapeutics Inc (CBAY.OQ)

CBAY.OQ on NASDAQ Stock Exchange Global Select Market

6.47USD
15 Jul 2019
Change (% chg)

-- (--)
Prev Close
$6.47
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
333,079
52-wk High
$14.00
52-wk Low
$4.82

About

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. The Company's product candidates include Arhalofenate, MBX-8025 and MBX-2982. Arhalofenate is used to treat gout. MBX-8025 is a... (more)

Overall

Beta: 2.08
Market Cap(Mil.): $358.81
Shares Outstanding(Mil.): 43.76
Dividend: --
Yield (%): --

Financials

  CBAY.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -1.06 -- --
ROI: -182.71 8.96 14.49
ROE: -308.78 10.09 15.79

Earnings vs. Estimates